Your Participation Makes a Difference
AMNet is seeking addiction medicine and addiction psychiatry practices and their providers to join a practice-based research and quality improvement network. The APA, American Society of Addiction Medicine (ASAM), and Friends Research Institute created AMNet through a cooperative agreement with the National Institute on Drug Abuse (NIDA). AMNet, in collaboration with the American Academy of Addiction Psychiatry (AAAP), will address the opioid epidemic by helping practices and their providers drive quality improvement while creating a platform for future research. The network is focused on measuring and improving patient outcomes through the collection of data in PsychPRO - APA's CMS-Qualified Clinical Data Registry.
APA members can join PsychPRO at no cost. Non-APA members who participate in AMNet will gain complimentary access to PsychPRO through July 31st, 2023, after which there will be a nominal annual fee. AMNet members receive free CME clinical and research webinars to address the opioid epidemic.
If you wish to join AMNet, please complete this 5-minute survey to check your eligibility.
About AMNet
Addiction medicine and addiction psychiatry office-based practices play an important role in responding to our nation's devastating opioid epidemic. Yet, little is known about the type of patients treated in these practices, the services they receive, and their clinical outcomes. Practices often have limited opportunities to organize their patient data to inform quality improvement efforts and are rarely invited to participate in clinical research. Although much is known about opioid treatment programs (OTP) and their patients, relatively little is known about providers and the patients they treat for substance use disorders, in office-based practices, non-OTP outpatient programs, community health centers, and community mental health centers.
AMNet is supported by the National Institute on Drug Abuse (5U01DA046910), the Department of Health and Human Services, and the Patient Centered Outcomes Research Trust Fund. AMNet was created to address the nation's opioid epidemic by forging a practice-based research and quality improvement network.
AMNet participants will receive complimentary access through July 2023 to PsychPRO, APA’s CMS-Qualified Clinical Data Registry. PsychPRO offers clinician- and patient-reported outcome measures (PROMs), accessible via its clinician and patient portals, and an interactive dashboard to visualize patient-level information and facilitate data comparisons for quality improvement initiatives.
AMNet's addiction-related outcome measures in PsychPRO include:
- Brief Addiction Monitor (BAM)
- TAPS Tool
- Treatment Effectiveness Assessment (TEA)
- Short Opiate Withdrawal Scale (SOWS)
- Clinical Opiate Withdrawal Scale (COWS)
- Visual Analog Scale for Opioid Craving (VAS)
- Patient Health Questionnaire (PHQ-2+1)
- PROMIS Pain Interference
In addition, psychiatric measures available in PsychPRO include:
- DSM-5 Cross-cutting measure
- PHQ-9
- GAD-7
Patients can complete these tools online, prior to their visit, or in office on tablet computers. Patient responses to measures will generate graphics, visualizing treatment progress over time.
PsychPRO's Interactive Dashboard Preview
PsychPRO offers options for patient-reported data applications that meet your practice and patient needs. The TetherAll app by TryCycle offers AMNet’s priority PROMs, while BH Works offers the full array of the AMNet and PsychPRO measures. Through the TetherAll app, patients can complete PROMs on their smartphones while BHWorks is available through a web browser.
Click each image below for more dashboard views:
Who Should Participate in AMNet?
We are seeking practices and their providers including physicians, nurse practitioners, and physician assistants who prescribe any formulations of buprenorphine or naltrexone in a wide variety of outpatient settings, including:
- Office-based Opioid Treatment Practices (OBOTs)
- Intensive Outpatient Programs (IOPs)
- Outpatient Programs (OPs)
- Community Health Centers (CHCs, FQHCs)
- Community Mental Health Centers (CMHCs)
Practices in health care and academic institutions, with or without EHRs, that regularly treat patients with opioid use and other substance use disorders are welcome. Practices can be located in urban, suburban, or rural areas. Telemedicine practices are eligible. We are currently not seeking providers in federally regulated opioid treatment programs (OTPs) because more is known about their patient outcomes than in other settings. In order for a clinician to participate, practice leadership must also agree for the practice or clinic to join.
Providers are eligible regardless of their membership status in APA, AAAP or ASAM.
Benefits of Joining AMNet
- Real-time data to track patients' progress
- Potential credit toward MOC Part IV Certification
- Free CME webinars
- Support in the use of AMNe
- Opportunity to participate in research
Complete the Survey Today
If you wish to join AMNet, please complete this 5-minute survey to check your eligibility.
Contact Us
If you have additional questions, please contact us at [email protected].